END OF THE GENTILE AGE i s
in SIGHT, BUT
“THE END OF LOIMOS IS NOWHERE IN Sight”
Announcement From A World AIDS Conference
So after more than 30 years of human Expertise,
Human Effort to end the deadly infectious Disorder
Failed to End a Great Judgment for Sexual Behavior!
It marked a “Beginning of Sorrows” and it will not End
Until a 2nd Advent of the One grieved by man’s Lifestyle!
August 5, 2008
http://www.tribulationperiod
Romans 1:26-28 – For this cause God gave them up unto vile affections: for even their women did change the natural use into that which is against nature: [27] And likewise also the men, leaving the natural use of the woman, burned in their lust one toward another; men with men working that which is unseemly, and receiving in themselves that recompence of their error which was meet. [28] And even as they did not like to retain God in their knowledge, God gave them over to a reprobate mind, to do those things which are not convenient;
Ephesians 4:17-19,30-32 – This I say therefore, and testify in the Lord, that ye henceforth walk not as other Gentiles walk, in the vanity of their mind, [18] Having the understanding darkened, being alienated from the life of God through the ignorance that is in them, because of the blindness of their heart: [19] Who being past feeling have given themselves over unto lasciviousness, to work all uncleanness with greediness. [30] And grieve not the holy Spirit of God, whereby ye are sealed unto the day of redemption. [31] Let all bitterness, and wrath, and anger, and clamour, and evil speaking, be put away from you, with all malice: [32] And be ye kind one to another, tenderhearted, forgiving one another, even as God for Christ’s sake hath forgiven you.
In the late Seventies I included HIV in my lecture series as one of the three phenomena listed as marking “the beginning of sorrows,” which was to precede the Tribulation Period.
It was to continue an indefinite period of time and continue in
to the Tribulation Period.
I was teaching biology and earth sciences in the secular school system at that time and, as a scientist and theologian I predicted they would not find a cure for it before the Second Advent. The biblical word “loimos,” translated as “pestilence” in Christ’s Olivet Discourse, literally means “any deadly infectious disorder.” Since the character of the three phenomena listed in the Olivet Discourse were to follow the characteristics of the biblical word “odin,” translated as “sorrows,” and since “odin” means the pain associated with a woman’s birth pangs, which continues until the baby is born, I told audiences that they would not find a cure for HIV before the Second Advent of Christ, and the virus would continue until that time. It appears my application of the two words to conclude the HIV virus would continue, and that a cure would not be found until the 2nd Advent, was correct.
Begin Excerpt from Business News via World News
Progress but end of AIDS ‘not in sight’
Tamar Kahn
Science and Health Editor
August 5, 2009
MEXICO CITY — The 17th World AIDS conference opened this week , with global leaders warning against complacency and urging the world to do more to prevent the spread of HIV/AIDS.
“For the first time, fewer people are dying of AIDS and fewer people are becoming infected with HIV … (but) the end of AIDS is nowhere in sight,” the executive director of the United Nations joint programme on HIV/AIDS (UNAIDS), Peter Piot, said at a press conference .
For every person who started treatment, almost three more became infected, he said.
And although the world had made tremendous strides in getting treatment to HIV-positive people — 3- million of them in the developing world — twice as many people were still unable to get life-saving medication .
About 33-million people were living with HIV last year , 2.7-million became newly infected and 2-million died, according to UNAIDS.
Piot’s call for fresh energy in preventing new HIV infections was echoed by former Botswana president Festus Mogae, who urged African leaders in particular to devise new ways to combat the disease.
“Substantial progress has been made on treatment, but the (prevention) message isn’t getting through despite our best efforts,” he said. Sub-Saharan Africa is home to 22-million HIV-positive people, two-thirds of the global total.
The week-long conference is being held in Latin America for the first time in a bid to draw attention to regiona
l issues such as how to prevent HIV/AIDS spreading among men who have sex with men — a taboo subject in many conservative communities
in the region.
SA, with the world’s biggest HIV-positive population — 5,7-million people according to the latest estimates from the UN — and large HIV/AIDS research community, also features prominently on the programme.
SA’s Deputy Social Development Minister Jean Swanson-Jacobs expressed concern over the financial cost of providing life-long treatment to the growing number of HIV-positive patients in SA.
By June, 510000 patients had been enrolled in the government’s treatment programme, making it the largest in the world.
“We are anxious about the affordability of this programme — we need cheaper drugs, cheaper diagnostic tools, but most importantly we need to make HIV prevention effective.” The cost of treatment was a global concern, she said.
More than 90% of the patients receiving antiretroviral therapy at state clinics and hospitals were on relatively cheap first-line regimens, but in time many of them would need to switch to more expensive second-line therapy, the health department’s HIV/AIDS head, Nomonde Xundu, said.
Earlier in the day, Cape Town scientist Andrew Boule presented a study at a satellite session that highlighted drawbacks in using nevirapine for HIV-positive patients who were also infected with tuberculosis.
Patients who were co-infected with HIV and TB fared better if their cocktail of HIV drugs included efavirenz instead
of nevirapine as they were better able to suppress the virus and had fewer side effects than those receiving a nevirapine-based combination.
While the study, published this week in the Journal of the American Medical Association , does not have immediate implications for SA, which already provides efavirenz to patients infected with TB and HIV, it raises difficult questions for most other sub-Saharan African countries since they provide co-infected patients
with three-in-one pills containing nevirapine.
FAIR USE NOTICE: This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner.
We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more detailed information go to:
http://www.law.cornell.edu/uscode/17/107.shtml.
You may use material originated by this site. However, if you wish to use any quoted copyrighted material from this site, which did not originate at this site, for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner from which we extracted it.